Position in NVS
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$414,210
+$5,604 QoQ
Shares Held
2,643
-1.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#973
of 1,603 holders
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Quad-Cities Investment Group, LLC holds $3,030,725 across 5 Drug Manufacturers - General names. NVS ranks #4 (13.7% of the industry book) .
All Filings in NVS
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $414,210 | 2,643 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $408,606 | 2,675 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $382,313 | 2,773 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $360,226 | 2,809 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $339,917 | 2,809 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $331,095 | 2,970 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $263,223 | 2,705 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $311,129 | 2,705 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $334,923 | 3,146 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $304,312 | 3,146 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $317,651 | 3,146 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $320,451 | 3,146 | Shares | Sole | 2023-10-05 | |
| 2023-06-30 | $317,462 | 3,146 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $289,432 | 3,146 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $280,143 | 3,088 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $236,163 | 3,107 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $204,984 | 2,336 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $204,329 | 2,336 | Shares | Sole | 2022-02-02 | |
| No filing history on record for this holder in this stock. | ||||||